What is a good medical decision? A research agenda guided by perspectives from multiple stakeholders by Hamilton, Jada G. et al.
What is a good medical decision? A research agenda guided by 
perspectives from multiple stakeholders
Jada G. Hamilton, Ph.D., M.P.H.1, Sarah E. Lillie, Ph.D., M.P.H.2, Dana L. Alden, Ph.D.3, 
Laura Scherer, Ph.D.4, Megan Oser, Ph.D.5, Christine Rini, Ph.D.6, Miho Tanaka, Ph.D., 
M.P.H.7, John Baleix, M.D., M.P.H.8, Mikki Brewster, M.S.W.9, Simon Craddock Lee, Ph.D., 
M.P.H.10, Mary K. Goldstein, M.D.11, Robert M. Jacobson, M.D.12, Ronald E. Myers, D.S.W., 
Ph.D.13, Brian J. Zikmund-Fisher, Ph.D.14, and Erika A. Waters, Ph.D., M.P.H.15
1Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 
New York, NY
2Center for Chronic Disease Outcomes Research, Minneapolis VA Health Care System, 
Minneapolis, MN
3Shidler College of Business, University of Hawaii, Honolulu, HI
4Department of Psychological Sciences, University of Missouri, Columbia, MO
5Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
6Department of Health Behavior, University of North Carolina; UNC Lineberger Comprehensive 
Cancer Center, Chapel Hill, NC
7Health Services Research & Development Service, Department of Veterans Affairs, Washington 
DC
8Hawaii Medical Service Association, BCBS of Hawaii, Honolulu, HI
9St. Louis, MO
10Department of Clinical Sciences and Harold C. Simmons Comprehensive Cancer Center, 
University of Texas Southwestern Medical Center, Dallas TX
11Geriatric Research Education and Clinical Center (GRECC), VA Palo Alto Health Care System, 
Palo Alto, CA; Department of Medicine (Center for Primary Care & Outcomes Research), 
Stanford University, Stanford, CA
12Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN
13Department of Medical Oncology, Sidney Kimmel Medical Center, Thomas Jefferson University, 
Philadelphia, PA
Correspondence: Address correspondence to: Erika Waters, 660 S. Euclid Ave, Campus Box 8100, St. Louis, MO 63110; Tel: 
+1-314-747-5705; Fax: +1-314-747-1020; waterse@wudosis.wustl.edu. 
Conflict of Interest: The authors declare that they have no conflicts of interest. The views expressed in this article are those of the 
authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.
Human and Animal Rights: This article does not contain any studies with human participants performed by any of the authors.
HHS Public Access
Author manuscript
J Behav Med. Author manuscript; available in PMC 2018 February 01.
Published in final edited form as:
J Behav Med. 2017 February ; 40(1): 52–68. doi:10.1007/s10865-016-9785-z.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
14Department of Health Behavior and Health Education and Department of Internal Medicine, 
University of Michigan, Ann Arbor, MI
15Department of Surgery—Division of Public Health Sciences, Washington University, St. Louis, 
MO
Abstract
Informed and shared decision making are critical aspects of patient-centered care, which has 
contributed to an emphasis on decision support interventions to promote good medical decision 
making. However, researchers and healthcare providers have not reached a consensus on what 
defines a good decision, nor how to evaluate it. This position paper, informed by conference 
sessions featuring diverse stakeholders held at the 2015 Society of Behavioral Medicine and 
Society for Medical Decision Making annual meetings, describes key concepts that influence the 
decision making process itself and that may change what it means to make a good decision: 
interpersonal factors, structural constraints, affective influences, and values clarification methods. 
This paper also proposes specific research questions within each of these priority areas, with the 
goal of moving medical decision making research to a more comprehensive definition of a good 
medical decision, and enhancing the ability to measure and improve the decision making process.
Keywords
decision making; shared decision making; decision quality; patient-centered care; physician-
patient communication; patient participation
Introduction
The Institute of Medicine identified patient-centered care as a critical component of 
healthcare quality (Institute of Medicine, 2001). Patient-centered care “is respectful of and 
responsive to individual patient preferences, needs, and values, and [ensures] that patient 
values guide all clinical decisions.” This principle extends beyond what is traditionally 
referred to as informed consent; it emphasizes that enabling patients to become active 
participants in making decisions about their healthcare, particularly via a process of shared 
decision making when decisions lack a clear evidence-based “right” choice, involve the 
consideration of both benefits and harms, or are clouded by conflicting expert 
recommendations and rapidly changing evidence, can result in more informed decisions and 
better quality of care.
One consequence of this increased emphasis on informed and shared decision making is 
growth in the development and testing of interventions that aim to foster good medical 
decision making by patients and healthcare providers (i.e., decision support interventions). 
However, researchers and healthcare providers continue to struggle with defining the 
necessary conditions or indicators of a good medical decision, and how to evaluate whether 
a good decision has been made (Elwyn & Miron-Shatz, 2010; Ratliff et al., 1999). Yet, to be 
effective, such interventions need to be guided by a clear operational definition of a good 
medical decision and have valid and reliable measurement approaches consistent with that 
definition. Achieving consensus on the definition of a good medical decision would 
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overcome a critical barrier to developing highly effective decision support interventions and 
would advance the science of medical decision making more generally.
As one step toward achieving greater clarity in conceptualizing how a good medical decision 
can be defined, measuring attainment of this goal, and ultimately helping people to make 
good medical decisions, members of the Society of Behavioral Medicine (SBM) Health 
Decision Making Special Interest Group and the Society for Medical Decision Making 
(SMDM) developed two complementary “crosstalk” sessions for the 2015 SBM and SMDM 
annual meetings titled “What is a ‘Good’ Medical Decision? Perspectives from Multiple 
Stakeholders.” Both sessions were highly interactive, attracted attendees from many 
disciplines, and featured representatives from key stakeholder groups invested in identifying 
and promoting good medical decision making: physicians, patients, insurance companies, 
decision scientists, and medical anthropologists.
In each session, stakeholders and audience members discussed case scenarios involving 
complex, contemporary medical decisions (see Supplementary Material) including the 
management of uncertain incidental findings identified through genomic sequencing; end-
of-life decision making with surrogate decision makers and complicated family dynamics; 
the cessation of colorectal cancer screening in older patients; and the use of surgery for low-
grade ductal carcinoma in situ of the breast. These discussions identified a number of 
important themes and critical gaps in scientific knowledge relevant to identifying good 
decision making. The conference sessions were audio-recorded and/or transcribed, and there 
were dedicated note takers. After both sessions had concluded, the planners of the 
conference sessions and participating stakeholders reviewed the audio-recordings and/or 
session transcripts and notes to identify the most salient topics. This paper describes key 
concepts and research needs that the co-authors recognize as pressing in the field. We first 
offer a brief summary of current knowledge about what constitues a good patient-centered 
medical decision, and identify potential gaps in the definiton of a good decision. We then 
discuss selected priority areas for future inquiry that stem from the conference sessions and 
the unique perspectives of the various stakeholders, and make recommendations about which 
research questions need to be examined in order to develop a more comprehensive 
understanding of good medical decisions.
Decision Making Research: General Background
Good medical decisions are most difficult to define in situations that are characterized by 
uncertainty and that lack an agreed upon “right” choice. Such situations are common in 
healthcare, where, despite an emphasis on evidence-based medicine, patients and providers 
frequently encounter complex decisions that lack adequate evidence or expert consensus to 
guide the selection of a particular option. Currently in such decision contexts, good medical 
decisions are often defined in three ways. First, that the process is good, in the sense that the 
decision is made with a consideration of factual and probabilistic health information, along 
with personal values and preferences (Sepucha et al., 2004). Ideally, this evaluation process 
is conducted using a shared decision making approach. Shared decision making requires that 
patients: 1) recognize that a decision needs to be made; 2) understand the features, risks, and 
benefits of available treatment options; 3) consider personal goals and preferences to 
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determine which treatment options are aligned most closely with their values; 4) are 
meaningfully involved in the decision making process with their healthcare provider 
(including expressing the desire to not participate further, when such a desire exists); and 5) 
arrive at a medical decision that is based on what is known about the options and is 
consistent with their values and preferences (i.e., a “value-concordant” decision; O’Connor 
et al., 2005; Stacey et al., 2014; Volk & Llewellyn-Thomas, 2012).
The second way that a good medical decision is defined is in the sense that the outcomes of 
the decision are good. These outcomes include the extent to which patients obtain a value-
concordant treatment, experience limited regret about the decision process and outcome, and 
are satisfied with the decision experience (Holmes-Rovner et al., 2007; Sepucha et al., 2013; 
Stacey et al., 2014). Although a good decision outcome could also involve a good health 
outcome (e.g., recovery from surgery without complications), having a good health outcome 
is not a required element (Elwyn & Miron-Shatz, 2010). For example, a patient who 
experiences a rare but severe surgical complication could be said to have engaged in a good 
decision process, if that decision was based on an informed decision making process and the 
patient experienced high satisfaction about the decision.
A third way of defining a good decision has been driven primarily by an economic or 
decision-analytic model of decision making. Specifically, that a good decision maker should 
focus on expected value, balancing the objective probabilities associated with different 
aspects of different options, and the extent to which each of those aspects is desirable (i.e., 
expected utility theory; von Neuman & Morgenstern, 1947). This perspective is reflected in 
medical decision making research via its emphasis on combining detailed probabilistic 
information about the risks and benefits of treatment options with personal values and 
preferences (i.e., desirability of outcomes), and then choosing the option that is most value-
concordant.
However, this is not the way most people make real decisions (J. Ryan & Sysko, 2007; S. K. 
Smith et al., 2009). Instead, we experience the world through lenses that distort objective 
probabilities in predictable ways (i.e., cognitive biases; Tversky & Kahneman, 1974). For 
example, people tend to focus primarily on the number of people affected by a hazard (i.e., 
the numerator), rather than placing this number in the context of the total number of people 
in the overall population (i.e., the denominator). This tendency commonly results in higher 
risk perceptions for a hazard described as affecting 1,286 out of 10,000 people than 24.14 
out of 100 people (Yamagishi, 1997). Another challenge to the economic model of decision 
making is that, in general, preferences about treatment options (and other issues) are 
constructed and labile rather than pre-existing and stable (Slovic, 1995). Simple changes to 
the way a treatment option is framed can drastically alter its desirability (McNeil et al., 
1982). Furthermore, the economic perspective does not account for past personal experience 
in decision making, nor the fact that decision makers are influenced by considerations at 
multiple levels of social influence, including the interpersonal level (e.g., family), 
organizational level (e.g., paid leave from work), community level (e.g., availability of 
specialty care within easy traveling distance), and policy levels (e.g., national policies 
regarding healthcare payment and reimbursement).
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Decision Making Research: Conceptual Frameworks
One of the earliest conceptual frameworks intended to address some of these realities and 
inform the development and evaluation of interventions for promoting good decision making 
is the Ottawa Decision Support Framework (O’Connor et al., 1998). According to this 
framework, decision quality is determined by having a good decision process (including 
engagement in shared decision making) and a good decision outcome (in the sense described 
above). This framework assumes that decision making is a multi-dimensional process that is 
affected by: specific characteristics of the decision (e.g., the urgency of the decision); 
decisional conflict (e.g., uncertainty about the course of action); knowledge and expectations 
of the health situation and treatment options and outcomes; personal values and preferences; 
support and resources needed to make and implement the decision at multiple levels of 
influence (e.g., family opinions, financial support, interest in making a decision); personal 
characteristics (e.g., age, gender); and clinical characteristics (e.g., education, counseling 
style).
This paradigm has been used to develop many decision support interventions, including 
decision aids, that are designed to help people participate in medical decisions (i.e., improve 
process) and to improve decision outcomes. These interventions often consist of electronic 
or paper-based tools that patients can use before or during a discussion with their healthcare 
provider. International standards, grounded in the principles of shared decision making, call 
for decision aids and other decision support interventions to: provide balanced information 
about the risks and benefits of the treatment options (including the option of no action) in a 
way that encourages objective evaluation of the risks and benefits while also minimizing 
cognitive biases (e.g., by using visual displays; Garcia-Retamero & Galesic, 2010), help 
patients determine which treatment option is most consistent with their personal goals and 
desires (i.e., values clarification and preference elicitation; Owens & Shekelle, 2013; M. 
Ryan & Farrar, 2000), and help patients communicate with their healthcare providers about 
how their preferences and values relate to the different options and to their overall healthcare 
goals (O’Connor et al., 2005). A recent Cochrane Collaboration Review showed that 
decision aids can improve both decision process (e.g., improved knowledge, expectations, 
and participation in decision making), and decision outcomes (e.g., reduced decisional 
conflict, and some evidence for increased value concordance) (Stacey et al., 2014).
However, having two criteria for defining a good decision (i.e., decision process and 
decision outcome) adds complexity to efforts to determine whether or not a single decision 
is good. One unanswered question is whether it is possible for a decision to be considered 
good if it was made via a good decision process (e.g., the patient had high knowledge of the 
treatment’s risks and benefits), yet it also resulted in a poor decision outcome (e.g., the 
patient experienced high regret about the results of the treatment). A related question is 
whether a decision can be considered good if specific elements of a single criterion conflict; 
for example, if a patient does not receive value-concordant treatment (poor outcome), but 
does have high satisfaction and low regret (good outcome). There is little empirical guidance 
about how to evaluate the overall quality of such decisions. Another related issue is that 
patients’ satisfaction with their selected decision option is likely to be conflated with its 
success, as suggested by research on decision outcome valence and counterfactual thinking, 
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which refers to the process of imagining alternatives to past events, usually in a direction 
that provides a better outcome than the one experienced (e.g., Hafner et al., 2016). For 
instance, a patient may have a good decision process (e.g., high knowledge of the 
treatment’s risk and benefits) that led to a value-concordant decision to select an option that
—as is often the case—was not without risks. Although those risks were known, and thus a 
complication would not necessarily have been unexpected, a poor clinical outcome is likely 
to reduce decision satisfaction and increase decision regret. In this case, was the decision a 
good one? It may be difficult to disentangle responses to negative clinical outcomes, 
although understanding whether and why an individual might still make the same decision in 
a given circumstance may be worthwhile.
Decision Making Research: Measurement Issues
Determining whether or not a decision is good is further complicated by unresolved issues 
related to measurement. This complication expresses itself in three ways. First, although 
formative shared decision making work promotes measurement of both decision process and 
outcome criteria, the majority of shared decision making measures are outcome-related 
(Scholl et al., 2011). Additional development of measures of decision process constructs is 
needed (e.g., informed about options and outcomes, involvement in the decision). The 
second issue is how to measure specific constructs. For example, patient preferences are 
typically measured using patient-reported attitude scales, or by using values and preference 
elicitation methods such as utility elicitation, conjoint analysis, or analytic hierarchy 
processing (Liberatore & Nydick, 2008; O’Connor et al., 1998). However, there is evidence 
to suggest that different measurement methods elicit different patient preferences (e.g., 
Pignone, Brenner, et al., 2012). The third issue relates to the use of patient-reported versus 
observer measures, particularly for shared decision making. Measures of shared decision 
making typically assess the extent to which the patient is informed about key facts (i.e. 
knowledge), the decision is concordant with patient values (i.e., value concordance), and 
patients are a part of the decision making process to the degree they desire (i.e., 
participation). These constructs are predominately assessed with patient-reported measures, 
which may be subject to biases in recall or social desirability. Observer measures could help 
to address such limitations and provide a more comprehensive understanding of these 
constructs. Although some recently-developed observer measures exist (e.g., Observer 
OPTION; Elwyn et al., 2005), research in this area is vastly underdeveloped. Furthermore, 
even observer measures can be biased and/or have measurement error (Hoyt & Kerns, 1999).
Situated in the context of current scientific understanding of decision making and decision 
quality, stakeholders and audience members at the SBM and SMDM conference sessions 
agreed with the importance of both decision process and outcomes as criteria for a good 
decision. However, additional issues were identified as being central to answering the 
question, “what is a good decision?” These issues included interpersonal factors, structural 
constraints, affective influences, and values clarification methods. These issues are highly 
relevant to patients’ experiences of both the process and outcomes of medical decision 
making; yet, each issue has gaps in scientific knowledge that limit the ability to develop a 
comprehensive definition of good decision making. We offer a brief overview of these topic 
areas and outline specific research questions that need to be pursued in order to ultimately 
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achieve clarity regarding what makes a good decision. This overview is not intended to be 
comprehensive, but rather a starting point from which to begin to examine these complex 
issues.
Research Recommendations
Interpersonal Factors
Although most commonly-used medical decision making theories focus primarily on the 
individual decision maker, stakeholders in both conference sessions noted the importance of 
recognizing that decision making unfolds in a social context populated by healthcare 
providers, a spouse or partner, family members, friends, and other people with similar health 
challenges. As a result, it is critical to consider the multiple ways that these diverse 
interpersonal relationships can shape the process and outcomes of a good medical decision, 
and how they can be affected by the process and outcomes of decision making.
Relationships between patients and their healthcare providers are pivotal in influencing 
medical decision making. Research on shared decision making and patient-provider 
communication has traditionally examined health decisions made in clinical settings, 
including decisions about medical screening, treatment, and lifestyle changes. Studies in this 
area have often been descriptive in nature, with a good decision considered to occur when 
patient-provider interactions cover information deemed critical to health decisions (e.g., 
Leyva et al., 2015; Nyrop et al., 2015) or display key communication features (e.g., the 
extent to which they demonstrate shared decision making; Boss et al., 2015). The 
interpersonal nature of health decision making is inherent to this line of research; yet, past 
work has not necessarily acknowledged the fact that compared to their healthcare providers, 
patients are often at a disadvantage when presented with a health decision because of the 
novelty, complexity, and stressfulness of the medical challenges they face. As one patient 
stakeholder explained, “the fundamental challenge that I see from the patient standpoint [is 
that] everybody else in the game gets to play it more than once…We [patients] have to live 
with the outcome or not live and it is that distinction between the one shot lived experience 
and the translation of information…derived from populations which is in some sense the 
hardest thing for any patient to make sense of.”
The multiple sources of imbalance between patients and providers in a given health decision 
context—imbalances in decision experience, power, influence, emotions—may ultimately 
interfere with patients’ ability to achieve a good decision process and/or outcome (Willems 
et al., 2005). Several stakeholders in the SBM session noted that provider-directed education 
focused on building communication and motivational interviewing skills may help to 
overcome these challenges (Berger & Villaume, 2013). One stakeholder also noted the 
importance of “the notion of empathy and how it can be factored into the decision support 
process.” Thus, research is needed to examine the role of empathy in decision making as 
well as methods for fostering empathy, as it may help providers to better understand and 
respond to the perspectives of patients and their families facing difficult medical decisions 
(Halpern, 2007; Larson & Yao, 2005; Loewenstein, 2005). Furthermore, the quality of the 
patient-provider relationship may serve as an important outcome to consider when 
determining whether or not a medical decision is good. As one physician observed, “It 
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would be easy for me to say, well, anytime when one of the parties feels like they acquiesced 
or gave up couldn’t possibly be a good decision, but I think … preserving the clinical 
relationship with a patient is actually bigger than any one decision, [and] there will be times 
where one party might feel like they’re acquiescing on the decision or on the availability of 
something to preserve something greater.” Thus, the quality of a given decision may need to 
be judged in the context of how that decision impacts the ongoing, fluid relationships 
between patients and their providers (McMullen, 2012; van Kleffens et al., 2004).
In addition, it is important to consider the roles played by people in a decision maker’s 
social network, such as their family members and friends. On the one hand, people’s beliefs 
about the values, expectations, and preferences of close others can influence the choices they 
make (e.g., Mahler et al., 2008), regardless of whether these beliefs are objectively true. 
These beliefs have been studied in research on subjective norms (i.e., beliefs about whether 
other people approve or disapprove of a given behavior; Ajzen, 1991; Ajzen & Fishbein, 
1980), injunctive norms (i.e., beliefs about what people should do), and descriptive norms 
(i.e., beliefs about what most other people actually do; Cialdini et al., 1991). However, much 
is unknown about the source, nature, and effects of people’s beliefs about what their close 
others want and need them to do in a medical decision making context.
Members of a patient’s social network can also have direct influences on the decision 
making process, because patients often discuss important health decisions with a spouse or 
partner, family members, and/or friends (Ohlen et al., 2006; Schumm et al., 2010; 
Stiggelbout et al., 2007). Any influences stemming from these important relationships can 
have profound effects on the process and/or outcomes of health decision making given that 
decision makers spend a great deal of time with these individuals, value these relationships, 
and share goals and a future (Zhang & Siminoff, 2003). Indeed, evidence suggests that social 
network members can strongly influence people’s decision making, both in terms of discrete 
health decisions (such as those involving medical treatments; Rini et al., 2011) and ongoing 
health decisions (such as those involving lifestyle changes and behaviors; Rempel & 
Rempel, 2004). Of course, the preferences, values, or informational needs of these different 
individuals may vary from the patient’s and the healthcare provider’s, and the presence of 
these individuals in a medical consultation can increase the complexity of the interaction 
(Laidsaar-Powell et al., 2013). It is unclear how the various perspectives of these individuals 
can or should be weighed in order to achieve a good decision making process and to reach a 
good decision outcome. As a decision scientist stakeholder noted, “each participant in the 
process adds new constraints about what is possible, but no one person defines the outcome 
of what is best. It’s the combination of all of them that ultimately must determine what is 
right for one person in one situation.”
Similarly, when evaluating whether a medical decision is good or not, it may be necessary to 
consider the effects of a given decision on patients’ relationships with important people in 
their social networks. This issue was highlighted by stakeholders in the context of surrogate 
decision making (i.e., when an individual makes a decision on behalf of another person, such 
as a legal next of kin making decisions on behalf of a patient). As they explained, for some 
decision makers the experience “separates that person from the rest of the family [for] the 
rest of their lives.” Being ostracized from one’s family is not a good decision outcome, but 
Hamilton et al. Page 8
J Behav Med. Author manuscript; available in PMC 2018 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
neither is making a decision that is at odds with one’s knowledge and/or fundamental values. 
Hence, it is unclear how these various outcomes should be weighed in evaluating the quality 
of a decision, and research is needed to develop strategies for measuring these interpersonal 
outcomes.
Incorporating interpersonal factors into decision support interventions might improve the 
quality of the interventions and, consequently, facilitate good decision making processes and 
outcomes. This effort would require additional research to understand the various pre-
existing features of relationships that promote or hinder good decision making processes and 
outcomes, and the various ways the decision making process may affect relationships that 
are important to decision makers’ post-decision adjustment and quality of life in the future. 
Stakeholders in both sessions emphasized the importance of integrating effective sources of 
social support for medical decision making into clinical encounters. Research is needed to 
guide efforts to incorporate these support providers in a useful way. Such support could be 
provided by a partner, family member, friend, or peer. Patient navigators or lay health 
coaches—peers who are knowledgeable and experienced in a specific health context and can 
provide informational and emotional support—may be particularly useful (Braun et al., 
2012; Freeman & Rodriguez, 2011). As a patient stakeholder observed, patient navigators 
can “relate to the patient and help the patient relate to the doctor who is giving them the 
information… The navigator role is one of support whereby they work with the patient from 
the time they walk in until the time that they no longer need that kind of support. So the 
whole issue of decision making takes on a whole different dimension because they are not 
making that decision by themselves and there is someone else that can help them.”
Similarly, one of the decision scientists posited that the process of decision support may be 
improved by “relying on other people who have gone through the experience and accessing 
their experience in such a way so that it can be shared either directly or indirectly with those 
folks who are facing the decision before they choose.” A small body of research confirms 
that stories about other people’s experiences can influence health decision making (Denberg 
et al., 2006; Lacey et al., 2006; Shaffer et al., 2013). This kind of information may come 
from a variety of sources, including interactions with or observation of fellow patients 
(Meier et al., 2007), interpersonal communications with non-patients who describe others’ 
experiences (DiFonzo et al., 2012; Ford & Kaphingst, 2009), and the media (Crist, 2005; 
Van Stee et al., 2012). Considerable psychological research has been devoted to exploring 
how narratives, social networks, and social comparison processes influence people’s 
attitudes and behaviors (Allport & Postman, 1947; Aspinwall & Taylor, 1993; Burt, 1992; 
Contractor & Eisenberg, 1990; DiFonzo & Bordia, 2007; Festinger, 1954; Green & Brock, 
2002; Monge & Contractor, 2003; van Laer et al., 2014), but relevant theoretical models 
have rarely been used to understand medical decision making.
In summary, interpersonal factors likely play a pivotal role in achieving both good medical 
decision making processes and outcomes. Discussion among the stakeholders identified 
several critical questions in need of additional research as the field strives for a 
comprehensive definition of good decision making. These questions, presented in Table 1, 
range from the descriptive, to the conceptual/theoretical, to the applied in nature.
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Structural Constraints
For the purposes of this paper, we define structural constraints as contextual factors that 
impinge on patients’ abilities to make medical decisions (Gruskin et al., 2013). These 
constraints can occur at multiple levels of influence, including at the individual, 
interpersonal, organizational, community, and policy levels. We discuss two types of 
structural constraints: barriers to participating in the decision making process itself, and 
barriers to making quality decisions.
Much existing medical decision making research has focused on structural constraints that 
limit a patient’s ability to engage in the decision making process (i.e., shared decision 
making). One of the critical elements of shared decision making is that an informed patient 
actively participates in the decision. Constraints to informed and shared decision making 
that have been well-studied include lack of access to adequate information about different 
treatment options and their potential benefits and harms, an imbalance in power between the 
physician and the patient, and clinical practice barriers (e.g., physician time constraints) 
(Joseph-Williams et al., 2014; Legare et al., 2008).
Several structural constraints specifically related to the “engaged patient” criterion were 
identified by stakeholders as needing additional investigation by researchers. The most 
prominent constraint was that many patients are unaware that they have a voice in making 
decisions about their medical care (Craddock Lee et al., 2015). It was also not clear which 
strategies are most effective for engaging patients who are uncertain about their role in the 
decision making process or who may be distracted by emotional or practical concerns in the 
process of shared decision making.
Although the shared decision making approach—the pinnacle of patient-centered care— 
depends on the involved patient, organizations and clinics should not attempt to force 
engagement on patients who genuinely wish to defer to clinician judgment. As one 
stakeholder described, “many people are dealing with so many other issues in their lives that 
they are coming to a doctor because they don’t know what to do and they want to be taken 
care of…Their decision was to come to care or not come to care, [and] not [to] decide on a 
course of treatment.” Although some research has investigated the extent to which patients 
do and do not want to participate in decision making (Chewning et al., 2012), little is known 
about the psychosocial consequences of attempting to activate patients who may not want to 
be involved. Indeed, it could be that well-meaning attempts to engage patients in the 
decision process when they do not want to be involved could inadvertently produce harm 
(Sheridan, Harris, Woolf, & the Shared Decision-Making Workgroup of the US Preventive 
Services Task Force, 2004).
Structural factors can also impede the ability of patients to achieve concordance between 
their values, preferences, and the actual treatment that is carried out (i.e., value 
concordance). There is wide variability in the extent to which patients receive value-
concordant treatment (Winn et al., 2015). Several factors contribute to a lack of value 
concordance, including payment structures that reward higher healthcare utilization, poor 
infrastructure, and fragmentation of care (Ellis, 2000; Lara et al., 2001; Legare & Witteman, 
2013). Fragmentation of care was also identified during the conference sessions as limiting 
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which information is presented to patients (e.g., a surgeon might not mention non-surgical 
options that would be the purview of a different specialty provider, despite the fact that such 
options may be relevant to the patient).
Research is needed to identify and more effectively manage processes associated with 
fragmentation of care that inhibit the provision of alternative decision options (Stange, 
2009). Better understanding of the healthcare provider perspective is also needed, as it may 
illuminate how, why, and under what circumstances providers are more or less likely to have 
patients who receive value-concordant care. Qualitative methods could be especially useful 
for addressing these research questions (Drew & Schoenberg, 2011; Hay & Craddock Lee, 
2009). Another issue mentioned during both sessions is that population/public health 
recommendations, such as those related to the age for ceasing cancer screening, might not be 
appropriate for every individual. Research aimed at exploring opinions about this issue at the 
patient, provider, and system levels is needed.
Some structural factors influence patient decisions by restricting the extent to which a 
particular treatment option is available in real, practical terms. These factors are described in 
the published literature and were discussed extensively by stakeholders and audience 
members at both conference sessions. Specifically, patients who do not have access to 
reliable transportation, sufficient healthcare coverage, paid leave from work, and alternative 
childcare or eldercare services may not be able to choose a desired option because doing so 
is either logistically infeasible or has such severe negative consequences for other aspects of 
their lives that the choice is practically infeasible (Hunleth et al., 2016; Lara et al., 2001). 
One stakeholder reported that rural patients facing a diagnosis of ductal carcinoma in situ of 
the breast may choose mastectomy over lumpectomy plus radiation in part because it was 
not possible to make multiple trips to the treatment center located three hours away: “If three 
quarters of your patients do not have paid time off, then the choices they are making are not 
your clinical outcome choices. The choices are, ‘which of the options I can do and still get 
back to my life and not lose my job’.” Choosing mastectomy for ductal carcinoma in situ of 
the breast may not appear to be a good decision from the perspective of a healthcare 
provider or of clinical outcomes research. Yet, this decision is responsive to the patients’ 
intransigent structural constraints, which highlights an additional perspective that needs to 
be considered in evaluations of decision quality.
The need to finish treatment so that life could resume normality was mentioned several 
times in both conference sessions by multiple stakeholders. Research is needed to better 
explicate what it means to patients to return to “normal” and how to facilitate treatment 
decisions in a way that accommodates this need. A related question is whether it is possible 
to say that a good decision has been made, if it was made only because it was the treatment 
that placed the least logistical burden on the patient.
Some decision aids and patient education materials have been criticized for emphasizing 
individual decision making and responsibility while also overlooking structural factors that 
can constrain patients’ decisions (Hunleth et al., 2016). Providing information without 
considering structural constraints can cause emotional distress, as recounted by one 
stakeholder: “a patient who…[became aware] of treatment options that were not actually 
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viable, practical options for her [due to structural constraints] explicitly said, ‘I wish you had 
not told me this. I would be a happier person than I am now’…We need to pause and reflect 
upon the effects of our informational introductions.” However, another similarly situated 
patient might want to know all the options, and might consider methods of obtaining 
sufficient resources to make a particular option viable. These various critiques lead to an 
important series of research questions concerning structural constraints that are presented in 
Table 2, and can be used to guide future research.
Affective Influences
The role of affect in decision making is complex. Under certain circumstances affect can 
interfere with the process of making a medical decision. For example, fear can impair 
comprehension of information provided by providers, which impedes patients’ ability to 
become knowledgeable about their treatment choices (van Osch et al., 2014). As illustrated 
by a patient stakeholder in one of the conference sessions, “the room goes dark, things get 
quiet, and you say ‘what did you say?’ And they repeat. And eventually you bring yourself 
to some realization and understanding of what they said because the first thing that comes to 
your mind is that you are going to die.” However, affect also provides valuable guidance to a 
decision maker by helping them understand what is important to them, informing the 
perception of the risks and benefits of each choice, and facilitating the evaluation of 
disparate treatment outcomes (Peters et al., 2006; Pham, 2007; Slovic et al., 2005). This 
section examines two types of affective influences on medical decisions and on decision 
quality: as something that is experienced in the moment (i.e., “anticipatory” emotions) and 
as something that one imagines might be experienced in the future (i.e., “anticipated” 
emotions) (Loewenstein et al., 2001).
Ample research demonstrates that different anticipatory affective states (e.g., fear, anger, 
happiness, sadness, disgust) influence decisions differently (Lerner et al., 2015). However, 
the specific relationship between affect and decision making depends on a combination of 
patient factors and characteristics of the decision itself (Consedine et al., 2004). For 
example, one can have affective feelings toward a disease (e.g., fear), towards treatment 
options (e.g., fear, hope), and towards different aspects of treatment options (e.g., positive 
affect towards benefits, negative affect towards risks), and each of these considerations can 
have different effects on decisions. Whereas one person might forego screening due to fear 
of finding out she has cancer, another might undergo screening because he fears late 
detection (Consedine et al., 2004; Hunleth et al., 2016). Fear and concern can also prompt 
people to make decisions resulting in under-treatment of disease due to concern about 
experiencing side effects (Horne et al., 2007). Alternatively, patients may knowingly choose 
highly intensive treatments to maintain hope for the future (Agrawal et al., 2006), or to 
avoid, in one stakeholder’s words, worrying “about the future prospect of a risk…
continually, for the next few years.” Such decisions seem ideally suited to be facilitated via 
decision support tools, but interventions that incorporate examination of anticipatory 
affective states either preceding or following use of decision aids are very sparse (Stacey et 
al., 2014).
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People not only directly experience affective states in the moment, but they also anticipate 
how they might feel in the future. For example, healthy people often overestimate how much 
an illness or disability will negatively impact their lives (Halpern & Arnold, 2008; Ubel et 
al., 2005). Stakeholders in both conference sessions highlighted such affective forecasting 
errors as potential barriers to good decision making that need to be addressed. For instance, 
one decision scientist asked, “people do adapt and they do move forward…How do we give 
people some insight into that [process]?” Evidence suggests that narratives may be one tool 
that can reduce affective forecasting errors related to colorectal cancer screening (Dillard et 
al., 2010). Adapting and testing narrative interventions among other medical decision 
contexts is an incremental step to evolving this line of research. More research is needed to 
develop interventions that improve affective forecasting and to incorporate such 
interventions into decision support tools (Elwyn et al., 2010).
People also anticipate the extent to which they might feel regret in the future if a negative 
outcome were to occur (Loewenstein et al., 2001). In general, people who anticipate 
regretting a decision if it were to result in a negative outcome are more likely to engage in 
health protective behavior (Sandberg & Conner, 2008). However, unlike process regret (i.e., 
feeling regret about how a decision was made) and outcome regret (i.e., feeling regret about 
a bad outcome that occurred) (Connolly & Reb, 2005), anticipated regret has been relatively 
understudied in the context of clinical medical decision making and decision support. Most 
medical decision making research that examines anticipated regret treats it as a predictor of 
patient decision making separate from typical decision quality metrics such as decisional 
conflict (Hersch et al., 2014; van Dam et al., 2013). Although decisions made on the basis of 
anticipated regret can be considered good if a patient has an accurate conceptualization of 
how she would feel, anticipated regret is also subject to affective forecasting errors. Thus, if 
a patient bases a decision on anticipated regret but she inaccurately predicted how she would 
actually feel, the decision could be considered flawed. Research should examine the extent 
to which patients’ anticipated regret is and is not subject to affective forecasting errors, and 
the conditions under which such inaccurate predictions are most and least likely to occur. 
Research could also examine the extent to which anticipated regret might lead patients to ask 
for someone else to make the decision so that they will not “blame themselves” if there is a 
poor clinical outcome.
It is also important to highlight that stakeholders in both conference sessions noted that 
providers not only feel anticipated regret about their patients’ potential negative health 
outcomes, but also outcome regret when their patients experience negative outcomes. 
Furthermore, both types of regret may influence providers’ treatment decisions and 
recommendations. However, provider regret and its implication for good decision making is 
severely understudied in the medical decision making literature (Feinstein, 1985; Mamede & 
Schmidt, 2014).
This collection of research findings and stakeholder input leads to several unanswered 
questions about affective states, their relationship to the process of medical decision making, 
and what it means to make a good medical decision (see Table 3). Improving understanding 
of these questions will help clarify the function of affect throughout the decision making 
process and, consequently, inform the development of conceptual models of good decision 
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making and improve the utility of decision aids and other decision support tools (Elwyn et 
al., 2011).
Values Clarification Methods
Stakeholders in both sessions described a need for improved, evidence-based methods for 
eliciting and clarifying patient values and preferences both within and outside of medical 
consultations (Bridges, 2003; M. Ryan et al., 2001). Values clarification methods (VCMs) 
are “methods to help patients think about the desirability of options or attributes of options 
within a specific decision context, in order to identify which option he/she prefers” 
(Pignone, Fagerlin, et al., 2012). VCMs are grounded in social psychology and have a rich 
history in a variety of fields, including conflict resolution, economic utility theory, and 
decision process theories (Kinnier, 1995). VCMs are grounded in economic utility theory 
and decision process theories and have been used increasingly in healthcare settings, and 
most often address treatment decisions (Witteman et al., 2016). VCMs include (but are not 
limited to) rating and ranking, balance sheets, as well as conjoint analysis and discrete 
choice experiments that utilize series of hypothetical choices to estimate values of options 
and outcomes (M. Ryan & Farrar, 2000; M. Ryan & Gerard, 2003). VCMs can take many 
forms, but are most often designed to be completed on paper, and in decision aids are 
presented after the information sections (Witteman et al., 2016).
Recent reviews (Fagerlin et al., 2013; Witteman et al., 2016) have pointed out that to date, 
VCMs lack systematic theoretical grounding, and as a result it is often not clear how to best 
achieve the objectives of VCMs, or even how to identify what the objectives of VCMs 
should be. For example, few methods explicitly present decision trade-offs, provide the 
opportunity for iterative decision making, or show how options align with different values, 
which may (or may not) be important for achieving value-concordant decisions (Witteman et 
al., 2016). Moreover, it is often assumed that taking more time to think carefully about a 
decision is inherently beneficial (de Vries et al., 2013), but this may improve feelings about 
the decision rather than the decision itself (Scherer et al., 2015).
Stakeholders in the sessions emphasized the importance of identifying ways that patients and 
providers can more effectively communicate with each other during consultations about 
patient values and preferences that are relevant to the medical decision (Elwyn et al., 2013; 
Siminoff et al., 2012; Zhang et al., 2010). Stakeholders also discussed several of the 
challenges facing patient preference elicitation research and VCMs. As one decision 
scientist pointed out, a central challenge is the fact that patients typically have not thought 
about their preferences in serious medical contexts because they have rarely “been down this 
road before.” As one patient representative explained, “I mean we talk about values but let’s 
be honest. Most patients don’t walk around saying ‘I’m a person who has this value.’ We 
construct this stuff in the moment when you ask us and we don’t have anything – yes, there 
are some innate things that we value but it doesn’t look like what we get when [decision 
support efforts] elicit values.” Because preferences and values are often constructed in the 
moment, they may change over time, or change depending on how they are elicited (e.g., 
rating and ranking vs. conjoint analysis; Pignone, Brenner, et al., 2012). Thus, a patient who 
appears to be making a value-concordant treatment decision at one moment in time or 
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following a particular elicitation method may appear to be making a value-discordant 
decision when her values and preferences are elicited at a different time or in a different 
manner. Research is needed to evaluate the extent to which values and preferences are 
malleable, and how this malleability influences whether and how value concordance can be 
used to identify good decisions.
Additional challenges can arise when patients have multiple, conflicting preferences. For 
example, a patient considering treatments for early-stage prostate cancer may have both a 
strong preference to avoid impotence, and a competing strong preference to get the prostate 
cancer out of his body. Given that surgical intervention can cause impotence, such a situation 
requires a difficult trade-off, is characterized by high uncertainty, and the patient’s ranking 
of these preferences may change frequently and be influenced by minor differences in 
elicitation method. Moreover, it may be the case that these conflicting preferences can never 
be resolved satisfactorily. It is unclear how to best support decision makers in such cases, or 
what the goal of VCMs should be when these cases arise. For instance, the goal could be to 
help the patient arrive at a stable preference structure. Alternatively, the goal could be to 
simply encourage a decision process that allows the patient to achieve a conventionally good 
decision outcome (e.g., to feel satisfied about the decision, to minimize regret) (Scherer et 
al., 2015).
Stakeholders also acknowledged that any development of innovative, theory-based VCMs 
needs to be tempered by the reality of actual patient decision making. As noted by a patient 
representative, “I can assure you that patients with breast cancer don’t move in this kind of 
definitive consideration as far as whether or not you made the best decision…some patients, 
all they want is to have it removed, let me go through the treatment I have to go through and 
get on with my life. All the other kinds of things that can seem so esoteric don’t mean a darn 
thing to me.” As exemplified by this perspective, current theoretical models of decision 
making and traditional VCMs may need to be expanded or revised to incorporate the various 
factors about which patients have preferences. For instance, VCMs often focus primarily on 
the risks and possible outcomes of treatment, yet focus less on the process of treatment (e.g., 
how to get treatment, when and whether treatment will end), which may be of great 
importance to a patient. Hence, measuring value concordance—and by extension, whether a 
decision is good—needs to evolve to allow patients to incorporate the specific factors that 
they have preferences about, rather than focusing exclusively on the factors that experts 
believe patients ought to have preferences about.
Stakeholders further emphasized the need for cultural competence. As the medical 
anthropologist noted, patients’ personal realities are embedded within larger social and 
structural contexts (Hoerger et al., 2013). For this reason, the universalizing “one-size fits 
all” approach to value and preference elicitation is likely to be suboptimal. In contrast, 
recognizing cultural differences between groups argues for adapting certain components of 
interpersonal communication algorithms and asynchronous measurement tools (typically 
developed in Western, upper-middle class environments) to the lives of other groups, whose 
unique life experiences contribute to different decision making processes and affective 
responses (P. B. Smith et al., 2006; Williams et al., 2008). Using a breast cancer treatment 
decision aid designed for Asian American women as an example, narratives may achieve 
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higher levels of value concordance when references to alternative choice costs and benefits 
are embedded in socially and structurally relevant contexts of families, friends, and work. At 
the same time, it is clear that variation occurs within groups on targeting dimensions such as 
cultural values and social norms (Oyserman et al., 2009). For this reason, it is important to 
develop VCMs that are sensitive and responsive to individual differences within cultural 
groups (Alden et al., 2014).
Moreover, current VCMs are limited in scope. As noted previously, they do not typically 
address variations in patient preferences over time, and also do not address the possibility 
that preferences and values may change in response to a medical course or a life event. As 
one physician pointed out, “we need follow up and close communication as we go forward 
because your values might change, the science may change, your ability to adhere to this 
might change or we may not be getting the outcome that we thought was important.” In the 
case of ongoing medical treatment, a decision that was once value-concordant may become 
discordant as values change with time, experience, and life events. VCMs, and decision aids 
more generally, also do not capture the temporal order of events that occur during the 
decision making process. VCMs are usually limited to assessing preferences for the over-
arching single decision (e.g., breast cancer treatment). Yet, patients make a series of 
decisions in more of a sequential and interrelated fashion: Will I have surgery or only 
chemotherapy? If chemotherapy, will I have my treatment at the local hospital or the breast 
cancer clinic two hours away? If the breast cancer clinic, will I drive or take a bus or ask my 
sister to take me? Each of the ‘follow-up’ decisions is influenced by the patient’s personal 
values and preferences (as well as structural constraints), and methods are needed that reflect 
this reality.
In summary, insights from both sessions emphasized the importance of eliciting patient 
values and preferences, but also identified a number of complexities in how this is achieved 
and how a decision is ultimately judged as value- or preference-concordant. Guided by 
stakeholder input from our sessions and gaps in the current literature, we propose several 
questions for further study, as presented in Table 4.
Conclusions
The field of medical decision making continues to strive toward achieving greater clarity 
about what it means to make a good medical decision. The traditional criteria, encompassing 
both the processes and outcomes of decision making, are necessary components for defining 
the quality of a medical decision. However, insights from multiple stakeholders reflecting a 
range of relevant disciplines and perspectives have highlighted the complexities inherent to 
achieving this goal. The major lesson learned from these sessions was that the traditional 
decision quality criteria and theoretical approaches alone are not sufficient to fully capture 
people’s lived decision experiences, and that a “one size fits all” approach to theories of 
decision making and definitions of what constitutes a good decision may not be appropriate.
Support for a more tailored approach to defining a good decision comes directly from the 
stakeholders, who emphasized that, although decision processes and outcomes are 
important, several other considerations complicated the decision process. For example, the 
Hamilton et al. Page 16
J Behav Med. Author manuscript; available in PMC 2018 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
decisions patients make are constrained by social and contextual factors that can shift 
patients’ priorities and preferences and complicate their decision making by introducing 
more salient issues than clinical effectiveness or other medical outcomes. Similarly, affect 
has powerful effects on the ways that individuals approach and make medical decisions. 
Finally, although patient values and preferences are important aspects of decision making, 
they are malleable and heterogeneous. Existing values clarification and elicitation methods 
are not sensitive to these realities of patient medical decision making. Unfortunately, current 
theoretical frameworks that guide medical decision making research do not sufficiently 
address these critical considerations. Research that explores these considerations, identifies 
the effects of these considerations on medical decisions, and integrates the results into 
theoretical models would advance the science of medical decision making and enhance 
interventions that aim to improve patient decision making.
Another reason one singular definition of a “good” decision may be insufficient stems from 
gaps in existing theoretical frameworks. Growing research suggests that the actual decision 
process is much more complex and dynamic than is indicated by many theoretical 
frameworks, which provide a static snapshot of a changing situation. For example, rather 
than a singular event, a decision may occur in phases over time (Beryl et al., 2016). Decision 
resolve (i.e., “firm determination” to maintain a decision, Beryl et al., 2016) also varies over 
time and plays a key role in whether or not a patient undergoes therapy. These complexities 
are not represented in current theoretical frameworks. These frameworks are also silent on 
whether decisions may involve feedback loops or interactions among key variables. It is also 
unclear whether people who make a greater number of challenging decisions learn how to 
navigate them more easily and in a way that is more consistent with their preferences. 
Medical decision making researchers might benefit from collaborations with scientists who 
examine complex multi-level phenomena (e.g., physical activity) from a socio-ecological 
perspective (Stokols, 1996).
In order to develop a comprehensive definition of decision quality and to advance the theory 
and practice of medical decision making, it is critical to consider novel factors that not only 
shape the process by which patients make medical decisions and the outcomes of those 
decisions, but also those factors that could serve as new metrics for identifying a good 
decision. This requires an acknowledgement and better scientific understanding of the real 
ways that patients make decisions. Further research is needed to fully understand how each 
of the issues raised in this article—interpersonal factors, structural constraints, affective 
influences, and values clarification methods—contributes to the definition (or multiple 
definitions) of good medical decision making. To truly comprehend these factors, it is 
critical to include the voices of the medically underserved in this research, including those 
who may be underserved due to race, ethnicity, income, education, literacy, geographic 
residence, language barriers, immigrant status, and acculturation. Community engaged 
research should be a key methodological strategy for achieving this goal (McCloskey et al., 
2011; Minkler & Wallerstein, 2008). Such research will expand the way in which 
researchers and providers ultimately define a good medical decision, and consequently will 
improve the ability to measure and intervene upon the decision making experience.
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Table 1
Suggested questions to guide research on the role of interpersonal processes in “good” medical decisions
Descriptive Questions Theoretical/Conceptual Questions Applied Questions
- In what situations and in what ways do 
interpersonal influences change patient 
decision making? Are these influences 
beneficial or detrimental to decision 
processes (e.g., obtaining knowledge) and 
outcomes (e.g., regret)?
- Which strategies are best for helping 
providers partner with patients when their 
respective cognitive and emotional 
reactions to the decision are highly 
disparate (e.g., when the decision is 
perceived as familiar or routine by the 
provider but is perceived as novel and 
overwhelming by the patient)?
- When during the decision making 
process will support offered by various 
individuals be effective versus ineffective?
- What does a good decision look like when a patient’s 
preferences contradict her/his provider’s preferences 
and/or the preferences of other social network members?
- How does incorporating the social and interpersonal 
nature of decision making change the definition of a 
good decision making process?
- When multiple decision makers are involved, should a 
good decision be defined by achieving a good decision 
for one person (e.g., the patient), a satisfactory decision 
for as many people as possible, or some other balance?
- Do current theoretical models of decision making apply 
to surrogate decision makers (i.e., those making 
decisions for others)?
- What sources of decision and 
social support are most effective for 
helping patients and their families 
make good medical decisions?
- Which healthcare providers should 
deliver sources of decision and 
social support (e.g., medical family 
therapists, social workers, clinicians, 
patient navigators) and how can they 
be appropriately reimbursed?
- How do we effectively integrate 
sources of decision and social 
support into complex decision 
contexts (e.g., high-stakes decisions; 
decisions with time constraints; 
individuals with difficult family 
dynamics involving poor 
communication, estrangement, 
geographic distance, etc.)?
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Table 2
Suggested questions to guide research on the role of structural constraints in “good” medical decisions
Descriptive Questions Theoretical/Conceptual Questions Applied Questions
- How often, for which patient 
populations, and for which treatments 
are decisions made primarily because 
structural constraints dominate the 
decision process?
- How do current decision quality 
metrics (e.g., treatment satisfaction, 
decision regret) and clinical outcomes 
(e.g., morbidity, mortality, quality of 
life) differ between patients whose 
decisions are and are not constrained by 
structural factors?
- What are the psychosocial 
consequences of introducing patients to 
an array of treatment options that may 
not be viable for them due to structural 
constraints? Relatedly, to what extent, if 
any, do decision support interventions 
“alienate” and/or “contribute to 
[patients’ feelings of] blame, guilt, or 
shame” for decisions that result in poor 
outcomes (Hunleth et al., 2016)?
- Can a decision be considered good if it is made solely on 
the basis of a structural constraint (e.g., lack of paid time 
off work is the dominant factor in a patient’s decision to 
undergo Treatment A instead of Treatment B)?
- How should consideration of structural constraints be 
incorporated into the decision making process and decision 
support tools—as a type of patient preference, or as a 
barrier to treatment that can be overcome? Furthermore, 
how can structural constraints be incorporated into patient 
decision making in ways that acknowledge their 
importance, but avoid perpetuating health inequities?
- How do decisions change when structural constraints are 
removed, and what implications does this have for defining 
a good decision?
- From a bioethics perspective, when, if ever, is it 
appropriate for a provider to not disclose a treatment option 
because the provider knows that the option is not feasible 
for the patient?
- Can collaborative teams 
comprised of social workers, 
decision psychologists, experts in 
preference and values elicitation, 
and others develop concrete 
strategies and programs that help 
patients overcome situational 
factors that might constrain their 
decisions to options that are 
feasible, rather than preferred?
- How do state and/or nationwide 
policies that reduce or eliminate 
common structural constraints to 
decision making affect health 
economic outcomes (e.g., effects on 
quality-adjusted life years, QALYs; 
disability-adjusted life years, 
DALYs)?
- What are the implications of 
provider and healthcare system 
performance incentives and 
penalties, which are intended to 
influence both healthcare costs and 
outcomes, for the process and 
outcomes of patients’ medical 
decisions?
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Table 3
Suggested questions to guide research on the role of affective influences in “good” medical decisions
Descriptive Questions Theoretical/Conceptual Questions Applied Questions
- How, why, and under what conditions 
do patients make affective forecasting 
errors when making medical decisions, 
and what are the consequences in terms 
of their decision satisfaction and what it 
means to make a good decision?
- To what extent and under what 
conditions is anticipated regret subject to 
affective forecasting errors?
- How do instructions for evaluating 
decision choices that emphasize a focus 
on feelings versus focus on details affect 
the choices made?
- How does affect change throughout the 
decision making process, following use 
of decision aids, through the various parts 
of the treatment process (e.g., prior to, 
during, and after each radiation therapy 
session), and after the treatment process 
(i.e., after all decisions have been made)?
- How does a healthcare provider’s 
anticipated regret influence treatment 
recommendations and decision support 
strategies, and what are the implications 
for what it means for a patient to make a 
good decision?
- When, if ever, can a decision be considered good 
when it is made because a patient prioritizes affective 
considerations (e.g., hope, fear) over empirical medical 
evidence?
- Some decisions generate multiple affective states, 
some of which may conflict (e.g., a treatment that 
offers hope for extended survival but also frightening 
side effects). How do patients integrate the experience 
of these disparate affective states to arrive at a decision, 
and under what criteria should such a decision be 
considered good?
- What is the role of ideal affect in patient decision-
making?
- What is the relationship between anticipated regret 
and good decision making? Is it possible to identify 
situations when it is and is not appropriate for patients 
to base their decisions on anticipated regret?
- How should the use of affect be incorporated into the 
definition of a good decision outcome? Should high 
treatment satisfaction and low regret be supplemented 
by other affective states? If so, which affective states?
- How can patient decision support 
tools incorporate the concept of 
affective forecasting errors and their 
potential biasing influence on 
decisions? Furthermore, under what 
circumstances, if any, should decision 
support tools be designed to overcome 
the influence of affective forecasting 
errors on decisions?
- How might decision support tools 
include consideration of patients’ 
changing anticipatory affective states 
throughout the decision making 
process?
- How can we develop an array of 
decision support tools that facilitate 
good decision making for groups of 
individuals who may experience 
affective states differently and at 
different points in the decision 
process? Such work would likely 
require formative research to 
characterize patients’ affective 
experiences at different points in the 
decision making process.
- How can decision researchers help 
patients harness fear and other 
emotions to make good decisions? 
What strategies can be used to resolve 
fear when it is likely to impair 
decision making and utilize fear 
appropriately when it can improve 
decision making?
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Table 4
Suggested questions to guide research on the role of values clarification methods (VCMs) in “good” medical 
decisions
Descriptive Questions Theoretical/Conceptual Questions Applied Questions
- To what extent, and under what 
circumstances, are patient 
preferences malleable over time, 
context, and elicitation method?
- Are the values and preferences that 
are included in VCMs the same 
values and preferences that patients 
of different backgrounds care about?
- How does the malleability of patient preferences 
influence our ability to draw inferences about the 
quality of a decision based on value concordance?
- How can we incorporate the idea of values changing 
over time and experience in VCMs? Should VCMs 
include longitudinal follow-up to allow measurement 
of more distal outcomes?
- How can we approach the design of VCMs 
in a way that ensures that the values and 
preferences that patients of different 
backgrounds care about are adequately 
reflected?
- Can we develop VCMs that better address 
the fact that most medical decisions are not 
a single, discrete choice, but rather reflect a 
sequential paradigm?
- In what ways might VCMs encourage 
patients to consider the downstream 
consequences of a discrete decision?
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